Jayasekera, J.; Onukwugha, E.; Bikov, K.; Mullins, C.; … - In: PharmacoEconomics 32 (2014) 2, pp. 173-191
Metastatic prostate cancer patients with SREs incur higher costs compared to similar patients without SREs. SRE costs among older stage IV (M1) prostate cancer patients vary by SRE type, with spinal cord compression and concurrent surgery costing at least twice as much as other SREs. </AbstractSection> Copyright...
